Inventor · disambiguated record
Omri Gottesman
Also filed as: GOTTESMAN OMRI
18 granted patents·36 pending applications·33 citations·filing 2014–2025
91Inventor score
Top patents by PatentIndex Score
54 records- 0196US11879125B2GalNAc compositions for improving siRNA bioavailabilityEMPIRICO INC·Filed 2023·Granted Jan 23, 2024·3 cites·20 claims
- 0296US11116778B2Prodrugs of ALOX-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2020·Granted Sep 14, 2021·9 cites·9 claims
- 0395US11180757B117β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Nov 23, 2021·3 cites·30 claims
- 0494US11377658B2Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseasesEMPIRICO INC·Filed 2021·Granted Jul 5, 2022·2 cites·20 claims
- 0594US10787647B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2018·Granted Sep 29, 2020·10 cites·52 claims
- 0692US11753628B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2022·Granted Sep 12, 2023·1 cites·26 claims
- 0790US10941404B2Treatment of angiopoietin like 7 (ANGPTL7) related diseasesEMPIRICO INC·Filed 2020·Granted Mar 9, 2021·2 cites·20 claims
- 0886US2024141305A1Hsd17b13 variants and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0984US11845963B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2018·Granted Dec 19, 2023·1 cites·12 claims
- 1084US11485958B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2020·Granted Nov 1, 2022·1 cites·40 claims
- 1184US2025090559A1Prodrugs of alox-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2024·Application pending·0 cites
- 1282US12258564B2GalNAc compositions for improving siRNA bioavailabilityEMPIRICO INC·Filed 2023·Granted Mar 25, 2025·0 cites·20 claims
- 1380US2023031669A1Hsd17b13 variants and uses thereofREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1479US2023248752A1Prodrugs of alox-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2023·Application pending·0 cites
- 1578US12258563B2Modified oligonucleotidesEMPIRICO INC·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 1678US11708415B2Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1REGENERON PHARMA·Filed 2019·Granted Jul 25, 2023·1 cites·18 claims
- 1778US2025228883A1Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related ConditionsEMPIRICO INC·Filed 2024·Application pending·0 cites
- 1876US12312586B2Treatment of MST1 related diseases and disordersEMPIRICO INC·Filed 2024·Granted May 27, 2025·0 cites·8 claims
- 1976US2025333737A117ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOFREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 2075US11666588B2Prodrugs of ALOX-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2021·Granted Jun 6, 2023·0 cites·20 claims
- 2175US2024392295A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2024·Application pending·0 cites
- 2275US2025197863A1Galnac compositions for improving sirna bioavailabilityEMPIRICO INC·Filed 2025·Application pending·0 cites
- 2374US2024287523A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2024·Application pending·0 cites
- 2473US2023074280A1Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp transcriptsEMPIRICO INC·Filed 2022·Application pending·0 cites
- 2570US12359201B217ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereofREGENERON PHARMA·Filed 2019·Granted Jul 15, 2025·0 cites·39 claims
- 2670US2023374145A1Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding IL33 And IL1RL1REGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2769US11452738B2Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcriptsEMPIRICO INC·Filed 2020·Granted Sep 27, 2022·0 cites·15 claims
- 2869US2022340907A1Oligonucleotides for treatment of angiopoietin like 4 (angptl4) related diseasesEMPIRICO INC·Filed 2022·Application pending·0 cites
- 2968US2024175031A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3064US2025197859A1Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseasesEMPIRICO INC·Filed 2023·Application pending·0 cites
- 3163US12378556B2Treatment of angiopoietin like 7 (ANGPTL7) related diseasesEMPIRICO INC·Filed 2021·Granted Aug 5, 2025·0 cites·19 claims
- 3262US2024279663A1Treatment of angptl4 related diseasesEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3362US2025195555A1Treatment of hgfac related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 3462US2025250568A1Modified oligonucleotidesEMPIRICO INC·Filed 2025·Application pending·0 cites
- 3561US2024018523A1Galnac compositions for improving sirna bioavailabilityEMPIRICO INC·Filed 2021·Application pending·0 cites
- 3661US2025327127A1Small molecule treatment of mtres1 related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 3761US2025313841A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2025·Application pending·0 cites
- 3861US2025333732A1Treatment of sos2 related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 3959US2025368990A1Treatment of ms4a4e related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 4057US2021361693A1Process to inhibit or eliminate eosinophilic diseases of the airway and related conditionsEMPIRICO INC·Filed 2019·Application pending·0 cites
- 4157US2023357774A1Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseasesEMPIRICO INC·Filed 2021·Application pending·0 cites
- 4256US2025043281A1Treatment of fgg related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 4356US2024287519A1Treatment of dkk2 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 4456US2022084639A1Electronic Phenotyping Technique for Diagnosing Chronic Kidney DiseaseICAHN SCHOOL MED MOUNT SINAI·Filed 2021·Application pending·0 cites
- 4555US2024287518A1Treatment of mtres1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 4655US2024392299A1Treatment of mst1r related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 4753US2024254492A1Modulation of coasy expressionEMPIRICO INC·Filed 2022·Application pending·0 cites
- 4851US2024287517A1Treatment of plin1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 4950US2023407299A1Treatment of sos2 related diseases and disordersEMPIRICO INC·Filed 2021·Application pending·0 cites
- 5050US2022056444A1Process to inhibit or eliminate eosinophilic diseases of the airway and related conditionsEMPIRICO INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Omri Gottesman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →